Research
Hormonal
Low-carbohydrate diets can induce remission of type 2 diabetes, with clinical trials showing >50% remission rates in some studies.
If you have type 2 diabetes, a ketogenic diet (20-50g carbs/day) can potentially lead to remission. Work with your doctor to monitor blood sugar and adjust medications, as many patients reduce or stop medications within weeks.
GoodSupportsHIGH confidence
A clinical trial on 238 participants with type 2 diabetes for a mean of 8 years found that more than 50% reversed this disease on a ketogenic diet, with most reducing or eliminating medications in just 10 weeks [37].
Why this rating
Based on clinical trials and audits cited by the authors, which are considered more reliable than observational studies.
Source
Myths and Facts Regarding Low-Carbohydrate Diets
Nina Teicholz et al. · Nutrients · 2025
DOI 10.3390/nu17061047
narrative_reviewCited 7×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Low-carbohydrate diets improve cardiovascular risk markers (triglycerides, HDL, blood sugar, inflammation) and reduce 10-year ASCVD risk scores, despite potential increases in LDL-C in lean individuals.Good
- The 'keto flu' (flu-like symptoms during initial adaptation) can be avoided or alleviated by increasing sodium and mineral intake.Good
- Adherence to a low-carbohydrate diet (defined as ≤130g carbs/day or ≤25% calories) is sustainable long-term and nutritionally adequate, with high adherence rates reported in observational surveys.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →